Find a Tender
complete
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS): "NP49024 Growth Hormone". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
Not availableNo published reports
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published13 Jan 2025, 10:39 GMT | Last source update13 Jan 2025, 10:39 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-049ab4 | ||
What is being bought
This Framework Agreement is for the supply of Growth Hormone to health boards across NHS Scotland.
What changed
From the official release history
- tender value changed
13 Jan 2025, 10:39 GMT - Status changed to complete
13 Jan 2025, 10:39 GMT - Official notice release published
13 Jan 2025, 10:39 GMT - Submission deadline changed to published date
13 Jan 2025, 10:39 GMT - Published value updated to £16,000,000
13 Sept 2024, 12:29 BST - Status changed to active
13 Sept 2024, 12:29 BST - Official notice release published
13 Sept 2024, 12:29 BST - Submission deadline changed to 14 Oct 2024, 12:00 BST
13 Sept 2024, 12:29 BST - Buyer information updated
13 Sept 2024, 12:29 BST
Lots and requirements (2)
Published by the contracting authority
- Lot 1 · #1Growth Hormone Daily DosecancelledPublished valueNot publishedSupply of Growth Hormone (daily dose) to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Growth Hormone Long-ActingcancelledPublished valueNot publishedSupply of Growth Hormone (Long Acting) to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per product line.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
13 Jan 2025, 10:39 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 7 Jan 2025, 00:00 GMT · £15,300,000 - Contract active
Signed 7 Jan 2025, 00:00 GMT · £451,000
Commercial outcome and competition
Awards Merck Serono Limited, Novo Nordisk Ltd, Pfizer Ltd, Sandoz Not published · Not published · active Novo Nordisk Ltd, Pfizer Ltd Not published · Not published · active |
Contracts Growth Hormone Daily Dose £15,300,000 · signed 7 Jan 2025, 00:00 GMT · active Growth Hormone Long-Acting £451,000 · signed 7 Jan 2025, 00:00 GMT · active |
Bid statistics bids: 4 (lot 1) electronicBids: 4 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 4 (lot 1) smeBids: 0 (lot 1) bids: 2 (lot 2) electronicBids: 2 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) smeBids: 0 (lot 2) |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contracting authority GB-FTS-115937Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published